Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
| Business Activity | PASS |
| Debt Ratio (0.05%) | PASS |
| Cash Ratio (0.01%) | PASS |
| Receivables Ratio (0.00%) | PASS |
| Revenue Ratio (0.00%) | PASS |
| Overall | PASS |
| Date | EPS Est. | Reported EPS | Surprise % |
|---|---|---|---|
| 2026-08-04 | 1.41 | Pending | -- |
| 2026-05-05 | 1.21 | 1.09 | -9.5% |
| 2026-02-27 | 1.29 | 1.23 | -4.7% |
| 2025-11-04 | 1.20 | 1.32 | +9.9% |
| 2025-08-05 | 1.22 | 1.33 | +8.8% |
| 2025-05-06 | 1.22 | 1.36 | +11.3% |
| 2025-02-25 | 1.43 | 1.80 | +26.3% |
| 2024-11-05 | 0.84 | 0.86 | +2.8% |
| Period | Revenue | Net Income | EBITDA | Gross Profit | Op. Income | EPS |
|---|---|---|---|---|---|---|
| 2026-03-31 | $403.6M | $57.1M | $85.5M | $250.8M | $77.4M | 1.10 |
| 2025-12-31 | $412.5M | $68.3M | $95.1M | $247.3M | $83.9M | — |
| 2025-09-30 | $371.5M | -$100.4M | $91.9M | $230.6M | $83.7M | -1.86 |
| 2025-06-30 | $370.9M | $51.3M | $72.0M | $233.3M | $64.5M | 0.95 |
| 2025-03-31 | $372.0M | -$170.7M | $85.8M | $234.0M | $80.7M | -3.17 |
| 2024-12-31 | — | — | — | — | — | -6.52 |
| Date | Name | Role | Shares | Value |
|---|---|---|---|---|
| 2026-04-29 | LANE WENDY E. | Director | 1,225 | -- |
| 2026-04-29 | BRENNAN MICHELLE | Chairman of the Board | 1,225 | -- |
| 2026-04-29 | SCANNELL TIMOTHY J. | Director | 1,225 | -- |
| 2026-04-21 | HELLMANN ELISABETH A | Officer | 335 | -- |
| 2026-03-11 | SZYMAN CATHERINE M | Chief Executive Officer | 2,101 | -- |
| 2026-03-11 | YOUNG MICAH W | Chief Financial Officer | 873 | -- |
| 2026-02-27 | YOUNG MICAH W | Chief Financial Officer | 15,000 | $2.6M |
| 2026-02-27 | YOUNG MICAH W | Chief Financial Officer | 15,000 | -- |
| 2026-02-26 | YOUNG MICAH W | Chief Financial Officer | 2,034 | -- |
| 2026-02-12 | SZYMAN CATHERINE M | Chief Executive Officer | 11,141 | $1.5M |
| Holder | Shares | Value | % Held |
|---|---|---|---|
| Blackrock Inc. | 4.6M | $830.5M | 0.1% |
| Politan Capital Management LP | 4.6M | $820.7M | 0.1% |
| Pentwater Capital Management Lp | 3.2M | $567.9M | 0.1% |
| Barclays Plc | 2.7M | $490.7M | 0.1% |
| HBK Investments L P | 2.6M | $460.6M | 0.0% |
| Massachusetts Financial Services Co. | 2.3M | $418.9M | 0.0% |
| Vanguard Capital Management LLC | 2.1M | $366.6M | 0.0% |
| Vanguard Portfolio Management LLC | 2.0M | $358.8M | 0.0% |
| FMR, LLC | 1.5M | $259.4M | 0.0% |
| State Street Corporation | 1.4M | $257.1M | 0.0% |
$9.7B
11.87
1.128
4
$1.6B
$485.9M
5.22
0.1%
2,200
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| 2026-08-04 | $1.41 | Pending | — |
| 2026-05-05 | $1.21 | $1.09 | -9.5% |
| 2026-02-27 | $1.29 | $1.23 | -4.7% |
| 2025-11-04 | $1.20 | $1.32 | +9.9% |
| 2025-08-05 | $1.22 | $1.33 | +8.8% |
| 2025-05-06 | $1.22 | $1.36 | +11.3% |
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($180.00, 4 analysts) | |||
| 10 | $1,783.60 | +$16.40 (1%) | 0.1R |
| 50 | $8,918.00 | +$82.00 (1%) | 0.1R |
| 100 | $17,836.00 | +$164.00 (1%) | 0.1R |
| To Fair Value ($79.22) | |||
| 10 | $1,783.60 | +$-991.40 (-56%) | -3.7R |
| 50 | $8,918.00 | +$-4,957.00 (-56%) | -3.7R |
| 100 | $17,836.00 | +$-9,914.00 (-56%) | -3.7R |
- Elevated short interest (5.22 days to cover)
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| KNF | 0.389 |
| JHG | 0.388 |
| PH | 0.387 |
| VTI | 0.387 |
| IWM | 0.385 |
| Ticker | Correlation |
|---|---|
| HEKTAR.KL | -0.199 |
| LPTVQ | -0.181 |
| SCG.AX | -0.158 |
| HCMA | -0.149 |
| 7200.SR | -0.147 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.